News Samsung Biologics agrees $1.81bn takeover of PolyPeptide Samsung Biologics has agreed to buy PolyPeptide, a Swiss CDMO, in what is thought to be South Korea's largest biopharma acquisition to date.
R&D Setting the standard for sustainability in pharma Sustainability has become a crucial pillar in pharmaceutical development, with environmental concerns and resource management demanding immediate attention from organisations of all sizes a
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.